SCHEMBL1288415

SCHEMBL1288415

CCS(=O)(=O)Nc1ccc(-n2c(=O)n(C)c3cnc4ccc(-c5cccnc5)cc4c32)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 10/20 0.58
PIK3CD O00329 9/20 0.58
PIK3CA P42336 9/20 0.58
PIK3CG P48736 8/20 0.58
PIK3CB P42338 7/20 0.58
ATM Q13315 6/20 0.53
ATR Q13535 4/20 0.53
KCNH2 Q12809 1/20 0.53
AKT1 P31749 1/20 0.49
MET P08581 3/20 0.48
PIK3C2A O00443 2/20 0.48
PIK3C2B O00750 2/20 0.48
JAK3 P52333 2/20 0.48
PIK3C3 Q8NEB9 2/20 0.48
CHEK1 O14757 1/20 0.48
ABCB11 O95342 1/20 0.48
CSF1R P07333 1/20 0.48
PIK3R1 P27986 1/20 0.48
LTK P29376 1/20 0.48
CDK7 P50613 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12764653 0.95 MTOR (0.55) MTORPIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL12764675 0.88 MTOR (0.63) MTORPIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL12761145 0.84 PIK3CA (0.57) MTORPIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL927530 0.84 MTOR (0.56) MTORPIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL928143 0.82 MTOR (0.58) MTORPIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL928008 0.82 PIK3CD (0.62) MTORPIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL930048 0.82 MTOR (0.62) MTORPIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL926905 0.82 MTOR (0.62) MTORPIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL12764674 0.81 MTOR (0.59) MTORPIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL928379 0.81 MTOR (0.61) MTORPIK3CDPIK3CAPIK3CGPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2270008-B1 8-heteroaryl-3-alkyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as PI-3 kinases inhibitors NOVARTIS AG (CH) 2012-10-03 EP claimed
EP-2624831-A1 PHARMACEUTICAL COMBINATIONS Novartis AG (CH) 2013-08-14 EP disclosed
WO-2012047775-A1 PHARMACEUTICAL COMBINATIONS NOVARTIS AG (CH) 2012-04-12 WO disclosed
EP-1888578-A2 IMIDAZOQUINOLINES AS LIPID KINASE INHIBITORS Novartis AG (CH) 2008-02-20 EP disclosed
WO-2006122806-A2 1,3-DIHYDRO-IMIDAZO [4,5-C] QUINOLIN-2-ONES AS LIPID KINASE INHIBITORS NOVARTIS AG (CH) 2006-11-23 WO disclosed